Can the PPH treatment window be defined by oxygen-delivery risk, not blood-loss volume alone?
Postpartum hemorrhage is first a bleeding emergency. The immediate clinical priority is rapid recognition, hemorrhage control and evidence-based PPH treatment. The research question here is narrower: during severe blood loss, can we define the physiological window in which oxygen delivery is becoming inadequate before irreversible organ injury develops?
PPH care is moving earlier.
WHO's 2025 consolidated PPH guidance emphasizes early recognition and rapid response. WHO also highlighted acting at 300 mL blood loss when abnormal vital signs are present, rather than waiting only for a traditional 500 mL threshold.
The same guidance keeps established emergency measures central: uterine massage, uterotonics, tranexamic acid, intravenous fluids, examination, escalation of care, surgery when required and blood transfusion when indicated.
The key window may be physiological, not simply volumetric.
Blood-loss volume helps identify the event, but a future oxygen-delivery therapeutic would require its own patient-selection logic. The relevant question is whether a measurable combination of bleeding severity, vital signs, perfusion and oxygenation signals can identify a high-risk interval in which oxygen-delivery support could be studied as a complement to hemorrhage control and definitive transfusion care.
This is a protocol-development question, not a proposal to replace blood components, surgery, uterotonics, TXA or patient blood management.